By Michele Maatouk
Date: Thursday 16 May 2024
(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.
GSK initially retained a 12.9% stake in Haleon, but has...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news